BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18321361)

  • 21. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
    Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
    Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
    Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
    Etoh T; Nakai H
    J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
    Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours.
    Hall GH; Turnbull LW; Bedford K; Richmond I; Helboe L; Atkin SL
    Int J Oncol; 2005 Nov; 27(5):1283-8. PubMed ID: 16211223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
    Qi SY
    Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
    Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
    Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
    Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
    Kamat AA; Merritt WM; Coffey D; Lin YG; Patel PR; Broaddus R; Nugent E; Han LY; Landen CN; Spannuth WA; Lu C; Coleman RL; Gershenson DM; Sood AK
    Clin Cancer Res; 2007 Dec; 13(24):7487-95. PubMed ID: 18094433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.
    Gesundheit B; Klement G; Senger C; Kerbel R; Kieran M; Baruchel S; Becker L
    Med Pediatr Oncol; 2003 Dec; 41(6):516-26. PubMed ID: 14595708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
    Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.